Follow
Johan Gising
Johan Gising
Verified email at angstrom.uu.se
Title
Cited by
Cited by
Year
Functionalized 3-amino-imidazo [1, 2-a] pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors
LR Odell, MT Nilsson, J Gising, O Lagerlund, D Muthas, A Nordqvist, ...
Bioorganic & Medicinal Chemistry Letters 19 (16), 4790-4793, 2009
1282009
Trisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase Inhibitors
J Gising, MT Nilsson, LR Odell, S Yahiaoui, M Lindh, H Iyer, AM Sinha, ...
Journal of medicinal chemistry 55 (6), 2894-2898, 2012
822012
Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C
J Gising, LR Odell, M Larhed
Organic & Biomolecular Chemistry 10 (14), 2713-2729, 2012
502012
Synthesis, biological evaluation and X-ray crystallographic studies of imidazo [1, 2-a] pyridine-based Mycobacterium tuberculosis glutamine synthetase inhibitors
A Nordqvist, MT Nilsson, O Lagerlund, D Muthas, J Gising, S Yahiaoui, ...
MedChemComm 3 (5), 620-626, 2012
482012
A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3, 5-dichloro-2 (1 H)-pyrazinones
J Gising, P Örtqvist, A Sandström, M Larhed
Organic & Biomolecular Chemistry 7 (13), 2809-2815, 2009
372009
Direct palladium (II)-catalyzed synthesis of arylamidines from aryltrifluoroborates
J Savmarker, J Rydfjord, J Gising, LR Odell, M Larhed
Organic Letters 14 (9), 2394-2397, 2012
342012
Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocket
J Gising, AK Belfrage, H Alogheli, A Ehrenberg, E Åkerblom, R Svensson, ...
Journal of Medicinal Chemistry 57 (5), 1790-1801, 2014
282014
Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones
P Örtqvist, J Gising, AE Ehrenberg, A Vema, A Borg, A Karlén, M Larhed, ...
Bioorganic & medicinal chemistry 18 (17), 6512-6525, 2010
242010
Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold
JK Ekegren, J Gising, H Wallberg, M Larhed, B Samuelsson, A Hallberg
Organic & Biomolecular Chemistry 4 (16), 3040-3043, 2006
222006
Optimization and Evaluation of 5‐Styryl‐Oxathiazol‐2‐one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents
F Russo, J Gising, L Åkerbladh, AK Roos, A Naworyta, SL Mowbray, ...
ChemistryOpen 4 (3), 342-362, 2015
182015
Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB)
M De Rosa, L Lu, E Zamaratski, N Szałaj, S Cao, H Wadensten, ...
Bioorganic & Medicinal Chemistry 25 (3), 897-911, 2017
162017
Structural features determining the intestinal epithelial permeability and efflux of novel HIV-1 protease inhibitors
L Lazorova, I Hubatsch, JK Ekegren, J Gising, D Nakai, NM Zaki, ...
Journal of pharmaceutical sciences 100 (9), 3763-3772, 2011
132011
Efficient and Selective Palladium‐Catalysed C‐3 Urea Couplings to 3,5‐Dichloro‐2(1H)‐pyrazinones
AK Belfrage, J Gising, F Svensson, E Åkerblom, C Sköld, A Sandström
European Journal of Organic Chemistry 2015 (5), 978-986, 2015
122015
A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode
R Isaksson, J Lindman, J Wannberg, J Sallander, M Backlund, D Baraldi, ...
ChemistryOpen 8 (1), 114-125, 2019
92019
Syntheses of new tuberculosis inhibitors promoted by microwave irradiation
M De Rosa, J Gising, LR Odell, M Larhed
Upsala Journal of Medical Sciences 119 (2), 181-191, 2014
92014
Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease
AK Belfrage, E Abdurakhmanov, E Åkerblom, P Brandt, A Oshalim, ...
Bioorganic & Medicinal Chemistry 24 (12), 2603-2620, 2016
72016
ENABLE: an engine for European antibacterial drug discovery and development
M Olliver, L Griestop, D Hughes, AK Belfrage, J Gising, P Baranczewski, ...
Nature Reviews Drug Discovery 20 (6), 407-408, 2021
62021
N-(Methyloxycarbonyl) thiophene sulfonamides as high affinity AT2 receptor ligands
J Wannberg, J Gising, J Lindman, J Salander, H Gutiérrez-de-Terán, ...
Bioorganic & Medicinal Chemistry 29, 115859, 2021
62021
2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands
T Roy, NN Petersen, G Gopalan, J Gising, M Hallberg, M Larhed
Bioorganic & Medicinal Chemistry 66, 116804, 2022
42022
Diastereoselective Synthesis of N-Methylspiroindolines by Intramolecular Mizoroki–Heck Annulations
J Lindman, G Gopalan, C Palo-Nieto, P Brandt, J Gising, M Larhed
ACS omega 7 (36), 32525-32535, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20